Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Roberta Palla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Flora Peyvandi(University of Milan), Marlies van Lent(Radboud University Nijmegen), Naveena Fatima(National Institute Of Blood Disease and Bone Marrow Transplantation), Helen Platokouki(Iaso Children’s Hospital), Susan Halimeh(MVZ Labor Ravensburg), Michael Makris(University of Sheffield), Ondřej Zapletal(University Hospital Brno), Amy D. Shapiro(Apple (Israel)), Adrianna Williamson(Indiana Hemophilia and Thrombosis Center), Britta Lachmann, P. Quartey(St George’s University Hospitals NHS Foundation Trust), Monique van Haaften-Spoor(University Medical Center Utrecht), Jan Blatný(University Hospital Brno), Danijela Miković, Fraustina Hsu(NYU Langone Health), Marzia Menegatti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Simona Maria Siboni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Roger E. G. Schutgens(University Medical Center Utrecht), John Chapin(NewYork–Presbyterian Hospital), Helen Pergantou(Iaso Children’s Hospital), Jean‐François Schved(Hôpital Saint Eloi), Sarah Brown(University of Leeds), Muriel Giansily‐Blaizot(Centre Hospitalier Universitaire de Montpellier), Marco Boscarino(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Munira Borhany(National Institute Of Blood Disease and Bone Marrow Transplantation), Philippe de Moerloose(University of Geneva), Steve Austin(National Health Service), Nihal Özdemir(Marmara University), Yılmaz Ay(Dr. Behçet Uz Çocuk Hastalıkları Hastanesi), Paul Brons(Radboud University Nijmegen), Alessandro Casini(University Hospital of Geneva), Britta A. P. Laros‐van Gorkom(Radboud University Nijmegen), Marko Saracevic
Blood
December 2, 2016
Cited by 0


Related Papers